Becton, Dickinson and Company BDX Business Segments
| TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Interventional | $5.38B+7.2% | $5.29B+4.8% | $5.22B+4.8% | $5.11B+3.8% | $5.02B+2.4% | |
| Goodwill, Foreign Currency Translation, Gain (Loss) by Business | ||||||
| Interventional | -$67M— | -$104M— | -$35M— | -$75M— | —— | |
| Goodwill by Business | ||||||
| Interventional | $51.04B+0.6% | $50.97B+0.4% | $50.87B+0.1% | $50.84B+0.2% | $50.76B0.0% | |
| Revenue, remaining performance obligation, amount by Product | ||||||
| Consumables | $9B+7.1% | $9.2B+10.8% | $8.8B+3.5% | $8.6B+2.4% | $8.4B0.0% | |
| Products and/or Services | $10.1B+8.6% | $10.2B+10.9% | $10B+9.9% | $9.5B+4.4% | $9.3B0.0% | |
| Revenue by Geography | ||||||
| International | $8.69B+5.8% | $8.59B-0.6% | $8.59B+0.9% | $8.44B+0.5% | $8.21B-2.4% | |
| UNITED STATES | $12.68B+6.9% | $12.54B+4.5% | $12.46B+6.8% | $12.15B+6.4% | $11.86B+4.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Becton, Dickinson and Company break its business down?
- Becton, Dickinson and Company (BDX) reports segment other operating expense (income), net as a percent of revenues by business across 5 parts — BioPharma Systems, Connected Care, Interventional, Medical Essentials and Medical. Each is extracted from the segment footnotes and tracked over time.
- Where does Becton, Dickinson and Company's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Becton, Dickinson and Company's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
